Carlsmed, Inc.
$10.94
▲
1.04%
2026-04-21 05:53:01
carlsmed.com
NMS: CARL
Explore Carlsmed, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$293.52 M
Current Price
$10.94
52W High / Low
$17.19 / $8.5
Stock P/E
—
Book Value
$3.72
Dividend Yield
—
ROCE
-26.39%
ROE
-47.62%
Face Value
—
EPS
$-2.13
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
127
Beta
—
Debt / Equity
17.61
Current Ratio
8.87
Quick Ratio
8.74
Forward P/E
-6.02
Price / Sales
4.73
Enterprise Value
$146.61 M
EV / EBITDA
-4.84
EV / Revenue
2.9
Rating
Strong Buy
Target Price
$19.2
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | National Research Corporation | $18.18 | 35.65 | $413.53 M | 3.52% | 22.99% | 51.24% | $22.79 / $9.76 | $0.62 |
| 2. | LifeMD, Inc. | $5.06 | 15.69 | $242.75 M | 1.28% | -26.6% | -1.31% | $15.84 / $2.56 | $0.5 |
| 3. | Claritev Corporation | $22.45 | — | $349.35 M | — | 0.97% | 632.6% | $74.07 / $12.04 | $-10.51 |
| 4. | Zhongchao Inc. | $2.06 | — | $7.52 M | — | -1.4% | -24.88% | $12.18 / $1.44 | $6.39 |
| 5. | Definitive Healthcare Corp. | $1.05 | — | $147.1 M | — | -3.56% | -40.42% | $4.7 / $0.92 | $2.7 |
| 6. | Omada Health, Inc. | $14.04 | — | $827.31 M | — | -5.21% | -8.68% | $28.4 / $10.28 | $3.93 |
| 7. | Heartflow, Inc. | $31.38 | — | $2.69 B | — | -20.2% | -1.11% | $41.22 / $20.13 | $3.52 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 15.16 M | 13.07 M | 12.08 M | 10.19 M | 9.41 M | — |
| Operating Profit | -9.32 M | -9.04 M | -6.5 M | -5.72 M | -4.7 M | — |
| Net Profit | -8.61 M | -8.53 M | -6.77 M | -5.73 M | -4.72 M | — |
| EPS in Rs | -0.32 | -0.32 | -0.25 | -0.21 | -0.18 | -1.83 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Sales | 50.51 M | 27.16 M | 13.78 M |
| Operating Profit | -30.57 M | -24.12 M | -18.59 M |
| Net Profit | -29.63 M | -24.26 M | -18.9 M |
| EPS in Rs | -1.11 | -0.91 | -0.71 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total Assets | 130.12 M | 51.82 M | 14.02 M |
| Total Liabilities | 31.25 M | 122.45 M | 60.15 M |
| Equity | 98.87 M | -70.63 M | -46.13 M |
| Current Assets | 126.67 M | 49.35 M | 11.77 M |
| Current Liabilities | 14.28 M | 8.82 M | 7.44 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Operating CF | -28.98 M | -25.47 M | -17.48 M |
| Investing CF | -25.48 M | -0.18 M | -0.14 M |
| Financing CF | 100.13 M | 58.5 M | 3.18 M |
| Free CF | -30.33 M | -25.65 M | -17.61 M |
| Capex | -1.36 M | -0.18 M | -0.14 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue Growth % | 85.94% | 97.16% | — |
| Earnings Growth % | -22.17% | -28.36% | — |
| Profit Margin % | -58.67% | -89.3% | -137.16% |
| Operating Margin % | -60.53% | -88.8% | -134.93% |
| Gross Margin % | 75.31% | 73.8% | 71.88% |
| EBITDA Margin % | -55.28% | -83.9% | -131.52% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.